FDA Approves Prenosis' AI Tool to Predict Sepsis Risk Using Blood Biomarkers
-
The FDA approved Prenosis' Sepsis ImmunoScore, an AI tool that calculates a patient's risk of developing sepsis within 24 hours.
-
The tool uses 22 diagnostic and predictive parameters including biomarkers, vital signs, and demographics.
-
It was built using Prenosis' Immunix platform containing over 100,000 blood samples from 25,000+ patients.
-
Prenosis plans to sell the tool to hospitals nationwide and announce a distribution partnership with a large diagnostics company.
-
Sepsis affects at least 1.7 million US patients annually and early diagnosis is difficult; the tool aims to aid in early detection.